These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27463331)

  • 21. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
    Vogt M; Bajorath J
    Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similarity-based virtual screening with a bayesian inference network.
    Abdo A; Salim N
    ChemMedChem; 2009 Feb; 4(2):210-8. PubMed ID: 19072820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-Classified Multilevel Modelling of the Effectiveness of Similarity-Based Virtual Screening.
    Mazalan L; Bell A; Sbaffi L; Willett P
    ChemMedChem; 2018 Mar; 13(6):582-587. PubMed ID: 29106074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors.
    Schultes S; Kooistra AJ; Vischer HF; Nijmeijer S; Haaksma EE; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1030-44. PubMed ID: 25815783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of reduced graphs to encode bioisosterism for similarity-based virtual screening.
    Birchall K; Gillet VJ; Willett P; Ducrot P; Luttmann C
    J Chem Inf Model; 2009 Jun; 49(6):1330-46. PubMed ID: 19485397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple search methods for similarity-based virtual screening: analysis of search overlap and precision.
    Holliday JD; Kanoulas E; Malim N; Willett P
    J Cheminform; 2011 Aug; 3(1):29. PubMed ID: 21824430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening data fusion using both structure- and ligand-based methods.
    Svensson F; Karlén A; Sköld C
    J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity coefficients for binary chemoinformatics data: overview and extended comparison using simulated and real data sets.
    Todeschini R; Consonni V; Xiang H; Holliday J; Buscema M; Willett P
    J Chem Inf Model; 2012 Nov; 52(11):2884-901. PubMed ID: 23078167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusing similarity rankings in ligand-based virtual screening.
    Willett P
    Comput Struct Biotechnol J; 2013; 5():e201302002. PubMed ID: 24688695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of similarity measures for searching the dictionary of natural products database.
    Whittle M; Willett P; Klaffke W; van Noort P
    J Chem Inf Comput Sci; 2003; 43(2):449-57. PubMed ID: 12653508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of belief theory to similarity data fusion for use in analog searching and lead hopping.
    Muchmore SW; Debe DA; Metz JT; Brown SP; Martin YC; Hajduk PJ
    J Chem Inf Model; 2008 May; 48(5):941-8. PubMed ID: 18416545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing.
    Riniker S; Fechner N; Landrum GA
    J Chem Inf Model; 2013 Nov; 53(11):2829-36. PubMed ID: 24171408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trainable fusion rules. I. Large sample size case.
    Raudys S
    Neural Netw; 2006 Dec; 19(10):1506-16. PubMed ID: 16580815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarity search profiles as a diagnostic tool for the analysis of virtual screening calculations.
    Xue L; Godden JW; Stahura FL; Bajorath J
    J Chem Inf Comput Sci; 2004; 44(4):1275-81. PubMed ID: 15272835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual drug screen schema based on multiview similarity integration and ranking aggregation.
    Kang H; Sheng Z; Zhu R; Huang Q; Liu Q; Cao Z
    J Chem Inf Model; 2012 Mar; 52(3):834-43. PubMed ID: 22332590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rendering conventional molecular fingerprints for virtual screening independent of molecular complexity and size effects.
    Nisius B; Bajorath J
    ChemMedChem; 2010 Jun; 5(6):859-68. PubMed ID: 20425878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.